These votes running up to the gubernatorial election on November 3 highlight the differences between the legislature and the governor on cannabis issues.
Whether you’re an industry member, an allied business, an advocate for the plant or for rational public policy or personal freedom — and wherever you are in the country — the Massachusetts ballot initiative is your fight. It’s our fight.
Senate Minority Leader Chuck Schumer, along with Senators Cory Booker and Ron Wyden, reintroduced the Cannabis Administration and Opportunity Act, which would fully de-schedule cannabis, removing it from the Controlled Substances Act.
In a brutal missed opportunity to bring a medical program to the Gem State, the 2026 ballot will only have a prohibitionist measure left when it comes to drug policy.
Over the next two weeks, the Drug Enforcement Administration will conduct a historic, albeit fast-tracked, administrative hearing pursuant to the DOJ’s “Final Order” rescheduling cannabis to Schedule III in the hands of a state medical licensee or approved patient.
The hearing will consider the broader rescheduling of cannabis.
This is important. Rescheduling, particularly under a Republican administration, should motivate — and will likely ultimately force — states without medical access to…
The governor acted on a list of conditions unanimously approved by the Kentucky Board of Physicians and Advisors. HB 401, which would have accomplished this through the legislature, never even received a committee hearing in 2026.